Will SpaceX have the highest IPO Market Cap 2026?

TL;DR

The forecast is 81.6% Yes and 18.4% No. SpaceX has already established an approximately $2.1 trillion first-day closing capitalization, and Anthropic is the main remaining challenger. Watch Anthropic’s final offer price, outstanding-share count and first-day close: those determine whether it overtakes SpaceX before the eligibility window ends.

Context

This market compares companies that complete an IPO during 2026. The winning figure is total outstanding shares multiplied by the official closing price on the first trading day. It is not proceeds raised, enterprise value, an intraday peak or year-end capitalization. The eligibility deadline is December 31, 2026, at 11:59 PM ET. Worldwide listings qualify, with non-dollar figures converted under the specified exchange-rate rules.

As of November 3, SpaceX has completed its IPO and established the benchmark. Anthropic has filed publicly and advanced its preparations, but its November 2 amendment still leaves key offering terms blank. The contest is therefore asymmetric: SpaceX has a recorded result; Anthropic still needs both a completed listing and a sufficiently high first-day close.

Evidence

The historical backbone favors treating a large first-day gain as a real risk, not the default outcome. Jay Ritter’s May compilation covers 9,343 qualifying U.S. IPOs during 1980–2025, with a 19.0% mean and 7.0% median first-day return. The gap between the mean and median shows how large positive debuts pull up the average. Among 749 offerings during 2001–2025 with preceding annual sales of at least $500 million in inflation-adjusted dollars, the mean was 13.3%. That larger-revenue group is useful context, but it is not a direct reference class for a trillion-dollar AI offering.

The annual history also shows why a single average is insufficient. The following figures come from Ritter’s October 5 compilation:

Year	IPO count	Mean first-day return	Median first-day return
2019	113	23.5%	17.9%
2020	165	41.6%	26.2%
2021	311	32.1%	17.0%
2022	38	48.9%	9.3%
2023	54	11.9%	−0.5%
2024	73	15.3%	7.2%
2025	90	29.3%	13.7%

The October compilation reports 9,345 offerings for the full 1980–2025 period, while retaining the same 19.0% mean and 7.0% median. That is a publication-vintage difference, not evidence of a different economic pattern. These screened U.S. samples also exclude categories such as SPACs and ADRs, so they do not exhaust the market’s worldwide eligibility universe (historical underpricing study).

Against that background, SpaceX’s completed debut is the decisive fact. Its issuer announcement confirms that trading began on June 12, 2026. Nasdaq’s recap reports approximately $2.1 trillion in first-day capitalization and a price near $160.95.

The final prospectus supplies 7,380,196,910 Class A shares and 5,695,668,265 Class B shares after the base offering. At the reported closing price, that produces $2.1045605 trillion. Including the 83,333,333 additional shares produces $2.1179730 trillion. These are prospectus-based reconstructions, not an exchange-certified historical share snapshot. Approximately $2.11 trillion is the practical comparison benchmark. The remaining share-count ambiguity is small beside the uncertainty around Anthropic’s eventual capitalization.

Anthropic’s latest pricing evidence favors SpaceX. The Wall Street Journal’s November 2 report says prospective institutional buyers communicated valuations of $1.5–$1.6 trillion, below earlier discussion near $2 trillion. Those are buyer preferences, not an accepted price range or a verified order book. Still, they are more informative than an older aspirational headline.

At comparable post-offering outstanding-share capitalizations, the arithmetic is demanding. Anthropic needs 40.67% appreciation from $1.50 trillion, 31.88% from $1.60 trillion, 20.57% from $1.75 trillion or 5.50% from $2.00 trillion to exceed the $2.11 trillion benchmark. The lower end of the reported pricing discussion therefore requires a debut well above the broad historical median. It does not require an unprecedented outcome.

The word “comparable” carries much of the uncertainty. Anthropic’s registration amendment distinguishes common shares, preferred-share conversion, Amazon-note conversion, options, restricted stock units and other equity arrangements. It excludes unexercised options from outstanding shares. A fully diluted valuation can therefore overstate the capitalization relevant to this market. But the final offering quantities remain blank, so the evidence does not support imposing a precise discount on every valuation headline.

Execution evidence is stronger than a vague intention to list. Anthropic announced its public registration on October 26, then filed its November 2 amendment. Its issuer notice identifies international retail brokers and selling agents. Renaissance Capital anticipated a roadshow during the week of November 9 and a listing during the week of November 16. These preparations support a feasible listing before year-end. They do not establish final approvals, subscriptions or a binding trading date.

Anthropic’s operating record explains both the excitement and the pricing resistance. Its full quarterly revenue and operating-result history is below, in USD millions, from the November 2 amendment:

Quarter	Revenue	Operating result
Q1 2025	376	−935
Q2 2025	787	−1,200
Q3 2025	1,382	−3,089
Q4 2025	2,040	−2,836
Q1 2026	4,731	−1,667
Q2 2026	11,555	+974
Q3 2026	16,956	−567

The data shows rapid revenue expansion, but not a straight path to operating profitability. Adjusted operating margins also declined from 19% in Q2 to 15% in Q3. The filing reports approximately $895.4 billion in aggregate purchase and lease commitments. These are multiyear obligations, not immediate cash expenditure. Growth supports demand for the shares; weaker incremental economics and large commitments support valuation discipline.

OpenAI is a smaller immediate threat. Its CEO ruled out a 2026 IPO in September. That statement is not an irrevocable prohibition. It does, however, leave Anthropic as the main identified challenger rather than one of several equally advanced contenders.

What's non-obvious

A lower offer price does not translate one-for-one into a lower first-day close. Conservative pricing can leave more room for appreciation. Reporting explicitly describes investors anticipating that combination (buyer-indication report). The relevant question is the final capitalization after trading, not whether Anthropic accepts a less ambitious offering headline. The required gain remains substantial, but the starting valuation and debut return should not be read as unrelated facts.

The second overlooked point is that capitalization definitions can matter more than an extra decimal place in SpaceX’s benchmark. A fully diluted Anthropic headline and an outstanding-share SpaceX figure are not directly comparable. Yet the existence of that distinction does not prove a particular adjustment. Timing also works differently from ordinary valuation risk: a postponement beyond the deadline removes Anthropic from this contest, even if its eventual listing is highly successful. Anthropic’s substantial liquid assets and positive operating cash generation give it room to reject unattractive terms rather than list at any price.

Uncertainties

The most important missing evidence is Anthropic’s priced prospectus and final outstanding-share bridge. Those documents would establish the offer price, primary issuance, conversions and relevant share classes. Until then, reported valuations cannot be mapped precisely onto the resolution formula. A genuinely comparable valuation near the older $2 trillion discussion would leave a much smaller appreciation hurdle than the latest buyer indications.

Demand is the next gap. A verified order book, anchor commitments, allocation details and formal price revisions would help distinguish negotiating pressure from genuine weak demand. The historical record establishes that large first-day gains occur. It does not establish the return distribution for a listing of this scale and profile.

Completion remains unresolved. Preparations support a timely IPO, but no final issuer-confirmed trading date was established. The evidence also does not amount to an exhaustive audit of every global exchange or eliminate a reversal by another large private company. These uncertainties preserve a meaningful loss risk without displacing the central conclusion: SpaceX has the established result, and its principal challenger still faces both an execution deadline and a substantial capitalization hurdle.